| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8792780 | Journal of Cataract & Refractive Surgery | 2018 | 11 Pages |
Abstract
Patients treated with a combination of topical bromfenac 0.09% and dexamethasone 0.1% had a lower risk for developing CSME after cataract surgery than patients treated with a single drug.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Laura H.P. MD, Jan S.A.G. MD, PhD, Bjorn PhD, Frank J.H.M. PhD, Claudette A. MD, Oliver MD, PhD, Joaquim C.N. MD, PhD, Willem R.O. MD, PhD, Marie-José MD, PhD, Maurits V. MD, PhD, Ype P. MD, Alexander H.F. MD, José L. MD, PhD, Michael MD, PhD,